Periodic Reporting for period 1 - ChemoPredict (Predictive in vitro diagnostics test for individualized tailoring of chemotherapy in primary breast cancer)

Sividon established a prototype diagnostic assay - the ChemoPredict test - to stratify high-risk breast cancer patients and to help in deciding whether it is it necessary to treat the patient with taxanes in addition to anthracycline-based chemotherapy. Previous training and...